Rapamycin as a potent and selective inhibitor of vascular endothelial growth factor receptor in breast carcinoma

Angiogenesis is the process of new vascular formation, which is derived from various factors. For suppressing cancer cell growth, targeting angiogenesis is one of the therapeutic approaches. Vascular endothelial growth factor family receptors, including Flt-1, Flk-1 and Flt-4, have been found to pla...

Descripción completa

Detalles Bibliográficos
Autores principales: Muhammad Sakri, Muhammad Shahidan, Tengku Din, Tengku Ahmad Damitri Al-Astani, Jaafar, Hasnan, Gopalan, Vinod, Wan Abdul Rahman, Wan Faiziah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777331/
https://www.ncbi.nlm.nih.gov/pubmed/35037503
http://dx.doi.org/10.1177/20587384211059673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777331/
https://www.ncbi.nlm.nih.gov/pubmed/35037503
http://dx.doi.org/10.1177/20587384211059673

Ejemplares similares